Wind-down of stem-cell institute leaves a void
By Jeanne F. Loring,
Nature
| 08. 07. 2019
For the past dozen or so years, stem-cell researchers in California have been the envy of the world. In 2004, as a rebuke to the restrictions put in place in the United States by then-president George W. Bush on funding for human embryonic stem-cell research, Californians approved US$3 billion in taxpayer funds to support regenerative medicine. That essentially guaranteed that the state would become the centre of innovation in the field.
Since then, almost all of my research funding has come from the California Institute for Regenerative Medicine (CIRM). But not for much longer.
In June, CIRM announced that it was no longer accepting new grant applications. Its money is running out, leaving researchers with fewer resources to develop stem-cell-based therapies. That same month, several of us stem-cell scientists were featured in a documentary series that promoted unproven stem-cell treatments and was partially funded by a for-profit clinic facing federal charges. We learnt about the nature of the series after that clinic sent mass e-mails promoting it. The film-makers removed interview footage at our request.
This coincidence demonstrates the double-edged...
Related Articles
By Roxanne Khamsi, The Atlantic | 07.07.2026
When Ludivine Verboogen and Romain Alderweireldt’s third child was born in Belgium in late 2015, they marveled at his long fingers. Perhaps one day he will be a famous pianist, they thought. But soon Ludivine grew worried that her son...
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Michael Le Page , New Scientist | 06.25.2026
We now know the master gene that controls embryonic development in people. Called NANOG, its role has been identified by making precise changes to the DNA of fertilised eggs using a technique called CRISPR base editing.
The discovery might lead...
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...